At present, the NDRC's measures to regulate drug prices are increasing. Yesterday, the National Development and Reform Commission issued the "Drug-parity-come parity rule" (hereinafter referred to as the "Rules"), which further regulates the prices of medicines.
According to the "Daily Economic News" reporter, according to the announced schedule, since December 1st, the NDRC will carry out an ex-factory price survey on the drugs in its pricing range.
A new round of drug price adjustment starts
"Daily Economic News" reporter was informed that the NDRC's policy of adjusting drug prices is intensively introduced. A few days ago, the National Development and Reform Commission also issued the "Measures for Examining the Prices of Pharmaceutical Products (Trial)".
The National Development and Reform Commission stated that pharmaceutical dosage forms, specifications, packaging materials and forms have been constantly refurbished, and some companies have increased the price of pharmaceuticals by changing the dosage forms, specifications, or packaging, etc., and thus aggravating the public's burden of medical expenses.
The industry generally believes that this round of large-scale research starting from December 1st should be the prelude to the next round of drug price adjustment.
“A rational look will reveal that the high drug price is not a new word, and the NDRC lowers drug prices for the first time,†said Li Ling, an economics professor at the China Center for Economic Research at the Peking University’s National Development Research Institute. Drug prices are very frequent and very hard.
In response to these problems, the National Development and Reform Commission (NDRC) researched and proposed the management method of “according to the generic name of pharmaceuticals, selecting the most representative dosage form specifications to establish the maximum retail price, and other dosage form specifications based on representative products, and checking prices according to a reasonable price-to-price parity relationshipâ€.
The NDRC stated that the formulation of the “Rules†has been tried out for several years. The “Rules†clearly stipulates the principles and methods for the verification of the highest retail prices for different types, sizes or packages of the same drug.
At the same time, the National Development and Reform Commission stated that the formal implementation of the "Regulations" will further enhance the scientific and transparent pricing of the government and will play an important role in regulating the behavior of drug prices and restraining companies from changing the formulation package and increasing the price in disguised form.
According to Li Ling's rough statistics, not this time, in recent years, the NDRC has reduced the maximum retail price of some drugs for 28 times. On the other hand, “the price of medicine has fallen frequently, but the people have never felt itâ€.
According to the report of the China Investment Advisor on the pharmaceutical industry, the three-year journey of the new medical reform is drawing to a close, and the goal of the new medical reform has still not been realized, and the competent authorities are making greater efforts to find ways to ease the “high drug pricesâ€.
Reform the payment method or become the key
In November, the National Development and Reform Commission, the State Food and Drug Administration and other ministries and commissions have already carried out the rectification of the safety of drugs in 29 provinces and cities.
Debon Securities believes that drug prices are the main target of regulation. The rumors about investigating the ex-factory prices of drugs have been buzzing last year. Now the National Development and Reform Commission has begun the first step, demonstrating that the NDRC has strengthened its understanding of drug prices and its determination to control them, paving the way for reasonable pricing in the future.
Professor Gu Xie, a professor of the School of Government of Peking University and a specialist in the new medical reform project, told the Daily Economic News reporter: Drug prices are not pushed up by the tendering process. The fundamental reason for pushing up drug prices is the government's control over drug additions. The government has stipulated that only a 15% increase in price may be sold.
Gu Wei also believes that the rapid reduction of drug prices is very simple, that is, to notify the provinces of the price of all the hospitals, the bid price is the final sales price, the hospital can purchase and increase their own prices, but are not allowed to break through the "ceiling." Hospitals will definitely pick up the cheaper ones because the cheaper hospitals earn more.
In her article, Li Ling stated that falling drug prices does not equal to lowering drug charges, and the underlying causes of unreasonable drug use remain unresolved. The real burden on the people is high drug costs, not only reflected in the "price", but also reflected in the "quantity".
The deep-seated reason for “irrational use of medicine†still lies in the profit-seeking mechanism of hospitals and doctors. It is always the doctor who decides “demand†for patients.
In this regard, Li Ling said that under the stimulation of economic interests, the "prescription right" held by doctors directly points to the pocket of the patient rather than the patient's health; the patient cannot discern what is rational use of medicine and what is excessive use of medicine. Passively accepted.
"Solving the problem of unrealistically high drug prices, the reform of the payment method is the fundamental solution." According to Gu Zheng, the implementation of package payment is not a matter of detail, only the final cost. After the payment method is changed, whether there is a bid price will not matter, and whether it is a matter of increasing the price by 15% is also irrelevant. In any case, the final cost is so much. Through the reform of the payment system, the administrative pricing system has been left to an end, leaving it marginalized.
Daily Economic News
related news
Pharmaceutical retail profits shrank Sichuan pharmacy Otsuka turned to food
With the implementation of measures such as the “ban on sale†and “decrease orderâ€, the pharmaceutical retail market in Chengdu has undergone tremendous changes since the beginning of this year. The profit of pharmacies has dropped by 20% to 30%, and the revenue of some chain companies has decreased. The bosses have to think: in the end Shouldn't it "turn around" from industries that have been rolling for more than ten years and move to other industries?
Intense Competition Forces Jiuding Pharmacy Boss to Change
Ten months after the listing, Sichuan's first imported food exhibition center yesterday settled into the Chengdu Hi-tech Comprehensive Bonded Zone. The center was opened by Sichuan's first import and export food company registered in the bonded area, “Yi Mo Keâ€. However, what is surprising is that the owner of Yat Tak is Han Xiangwen, Chairman of Jiuding Pharmacy. Jiuding Pharmacy is a giant pharmaceutical retailer in Chengdu. Why did the owner of a pharmaceutical retail business enter the import and export food sector?
Yesterday, Han Xiangwen told reporters at Chengdu Daily that "the pharmaceutical retail market is too fierce and the profits are thin." A senior industry official also stated that since the beginning of the year, the pharmacy retail competition has become increasingly fierce. First of all, from January 1, 2011, Chengdu cancels the restraining order and no longer restricts the number and spacing of drug retailers. Second, the state has repeatedly reduced the retail price of pharmaceuticals, and profits have been greatly reduced; again, since 2011 On July 30th of the year, designated drugstores prohibited the sale of non-pharmaceutical products.
At present, Chengdu has more than 5,000 retail pharmacies, including more than 3,000 medical insurance services. At the Sichuan-Chongqing Summit, a senior management salon for China's pharmaceutical retail regions, a number of pharmacy owners told reporters that "the profit of Chengdu drugstores has dropped by 20% to 30%, and the pressure has doubled."
Han Xiangwen stated that under this background, he had to speed up the pace of transformation. At present, about 50% of the stocks in the three pharmacies have been transferred to Shupuma. "This is why some Jiuding pharmacies have changed their face into Shupuma."
Early adopters bonded advantages
Han Xiangwen said that compared with the pharmaceutical retail market, Chengdu’s import and export foods are still in the early stages of development and have great potential. At the same time, foreign food giants have been peeping at the Midwestern market for a long time. Chengdu is the best springboard for its entry into the western region. In addition, Sichuan's logistics industry has been vigorously developed in recent years and has continuously improved its logistics environment. It has also effectively reduced the cost of goods sales and shortened the transportation time.
Yesterday, Chengdu Commercial Daily reporter saw in Zone A of the Free Trade Zone that about three containers of red wine and wine imported from France, New Zealand and other countries had arrived in Chengdu and were placed in a warehouse with an area of ​​about 2,000 square meters. Among them, the price of wine is about 300 yuan to 700 yuan/bottle.
According to Han Xiangwen, the cost of lifting shipments from foreign factories to Shanghai customs and re-shipping bulk cargo to second-tier cities in Sichuan Province is about 3.728 yuan/bottle. If you choose to pick up goods from foreign factories - foreign ports - Shanghai - Chengdu will be transported by road The overall transportation cost is 3.561 yuan/bottle. However, a wine industry veteran told reporters that if you declare in Chengdu, you can actually reduce one link, but whether you can lower the price of high-end foreign wine in Sichuan still needs to be observed, “The profit margin of imported wine is already very high. Big, if the price is a few tens of dollars lower than other businesses, other businesses will also cut prices."
Statistics from Chengdu Customs show that from January to September this year, the total import and export volume of the Chengdu Hi-tech Comprehensive Bonded Zone was US$ 12.62 billion, an increase of 90.6% year-on-year, becoming the main force for the development of the province’s foreign trade.
However, Han Xiangwen emphasized that vigorously entering the import and export foods, especially the wine market, "is not to give up Jiuding pharmacy, Jiuding pharmacy is still an important part, but now the focus will shift to the import and export food industry."
According to the "Daily Economic News" reporter, according to the announced schedule, since December 1st, the NDRC will carry out an ex-factory price survey on the drugs in its pricing range.
A new round of drug price adjustment starts
"Daily Economic News" reporter was informed that the NDRC's policy of adjusting drug prices is intensively introduced. A few days ago, the National Development and Reform Commission also issued the "Measures for Examining the Prices of Pharmaceutical Products (Trial)".
The National Development and Reform Commission stated that pharmaceutical dosage forms, specifications, packaging materials and forms have been constantly refurbished, and some companies have increased the price of pharmaceuticals by changing the dosage forms, specifications, or packaging, etc., and thus aggravating the public's burden of medical expenses.
The industry generally believes that this round of large-scale research starting from December 1st should be the prelude to the next round of drug price adjustment.
“A rational look will reveal that the high drug price is not a new word, and the NDRC lowers drug prices for the first time,†said Li Ling, an economics professor at the China Center for Economic Research at the Peking University’s National Development Research Institute. Drug prices are very frequent and very hard.
In response to these problems, the National Development and Reform Commission (NDRC) researched and proposed the management method of “according to the generic name of pharmaceuticals, selecting the most representative dosage form specifications to establish the maximum retail price, and other dosage form specifications based on representative products, and checking prices according to a reasonable price-to-price parity relationshipâ€.
The NDRC stated that the formulation of the “Rules†has been tried out for several years. The “Rules†clearly stipulates the principles and methods for the verification of the highest retail prices for different types, sizes or packages of the same drug.
At the same time, the National Development and Reform Commission stated that the formal implementation of the "Regulations" will further enhance the scientific and transparent pricing of the government and will play an important role in regulating the behavior of drug prices and restraining companies from changing the formulation package and increasing the price in disguised form.
According to Li Ling's rough statistics, not this time, in recent years, the NDRC has reduced the maximum retail price of some drugs for 28 times. On the other hand, “the price of medicine has fallen frequently, but the people have never felt itâ€.
According to the report of the China Investment Advisor on the pharmaceutical industry, the three-year journey of the new medical reform is drawing to a close, and the goal of the new medical reform has still not been realized, and the competent authorities are making greater efforts to find ways to ease the “high drug pricesâ€.
Reform the payment method or become the key
In November, the National Development and Reform Commission, the State Food and Drug Administration and other ministries and commissions have already carried out the rectification of the safety of drugs in 29 provinces and cities.
Debon Securities believes that drug prices are the main target of regulation. The rumors about investigating the ex-factory prices of drugs have been buzzing last year. Now the National Development and Reform Commission has begun the first step, demonstrating that the NDRC has strengthened its understanding of drug prices and its determination to control them, paving the way for reasonable pricing in the future.
Professor Gu Xie, a professor of the School of Government of Peking University and a specialist in the new medical reform project, told the Daily Economic News reporter: Drug prices are not pushed up by the tendering process. The fundamental reason for pushing up drug prices is the government's control over drug additions. The government has stipulated that only a 15% increase in price may be sold.
Gu Wei also believes that the rapid reduction of drug prices is very simple, that is, to notify the provinces of the price of all the hospitals, the bid price is the final sales price, the hospital can purchase and increase their own prices, but are not allowed to break through the "ceiling." Hospitals will definitely pick up the cheaper ones because the cheaper hospitals earn more.
In her article, Li Ling stated that falling drug prices does not equal to lowering drug charges, and the underlying causes of unreasonable drug use remain unresolved. The real burden on the people is high drug costs, not only reflected in the "price", but also reflected in the "quantity".
The deep-seated reason for “irrational use of medicine†still lies in the profit-seeking mechanism of hospitals and doctors. It is always the doctor who decides “demand†for patients.
In this regard, Li Ling said that under the stimulation of economic interests, the "prescription right" held by doctors directly points to the pocket of the patient rather than the patient's health; the patient cannot discern what is rational use of medicine and what is excessive use of medicine. Passively accepted.
"Solving the problem of unrealistically high drug prices, the reform of the payment method is the fundamental solution." According to Gu Zheng, the implementation of package payment is not a matter of detail, only the final cost. After the payment method is changed, whether there is a bid price will not matter, and whether it is a matter of increasing the price by 15% is also irrelevant. In any case, the final cost is so much. Through the reform of the payment system, the administrative pricing system has been left to an end, leaving it marginalized.
Daily Economic News
related news
Pharmaceutical retail profits shrank Sichuan pharmacy Otsuka turned to food
With the implementation of measures such as the “ban on sale†and “decrease orderâ€, the pharmaceutical retail market in Chengdu has undergone tremendous changes since the beginning of this year. The profit of pharmacies has dropped by 20% to 30%, and the revenue of some chain companies has decreased. The bosses have to think: in the end Shouldn't it "turn around" from industries that have been rolling for more than ten years and move to other industries?
Intense Competition Forces Jiuding Pharmacy Boss to Change
Ten months after the listing, Sichuan's first imported food exhibition center yesterday settled into the Chengdu Hi-tech Comprehensive Bonded Zone. The center was opened by Sichuan's first import and export food company registered in the bonded area, “Yi Mo Keâ€. However, what is surprising is that the owner of Yat Tak is Han Xiangwen, Chairman of Jiuding Pharmacy. Jiuding Pharmacy is a giant pharmaceutical retailer in Chengdu. Why did the owner of a pharmaceutical retail business enter the import and export food sector?
Yesterday, Han Xiangwen told reporters at Chengdu Daily that "the pharmaceutical retail market is too fierce and the profits are thin." A senior industry official also stated that since the beginning of the year, the pharmacy retail competition has become increasingly fierce. First of all, from January 1, 2011, Chengdu cancels the restraining order and no longer restricts the number and spacing of drug retailers. Second, the state has repeatedly reduced the retail price of pharmaceuticals, and profits have been greatly reduced; again, since 2011 On July 30th of the year, designated drugstores prohibited the sale of non-pharmaceutical products.
At present, Chengdu has more than 5,000 retail pharmacies, including more than 3,000 medical insurance services. At the Sichuan-Chongqing Summit, a senior management salon for China's pharmaceutical retail regions, a number of pharmacy owners told reporters that "the profit of Chengdu drugstores has dropped by 20% to 30%, and the pressure has doubled."
Han Xiangwen stated that under this background, he had to speed up the pace of transformation. At present, about 50% of the stocks in the three pharmacies have been transferred to Shupuma. "This is why some Jiuding pharmacies have changed their face into Shupuma."
Early adopters bonded advantages
Han Xiangwen said that compared with the pharmaceutical retail market, Chengdu’s import and export foods are still in the early stages of development and have great potential. At the same time, foreign food giants have been peeping at the Midwestern market for a long time. Chengdu is the best springboard for its entry into the western region. In addition, Sichuan's logistics industry has been vigorously developed in recent years and has continuously improved its logistics environment. It has also effectively reduced the cost of goods sales and shortened the transportation time.
Yesterday, Chengdu Commercial Daily reporter saw in Zone A of the Free Trade Zone that about three containers of red wine and wine imported from France, New Zealand and other countries had arrived in Chengdu and were placed in a warehouse with an area of ​​about 2,000 square meters. Among them, the price of wine is about 300 yuan to 700 yuan/bottle.
According to Han Xiangwen, the cost of lifting shipments from foreign factories to Shanghai customs and re-shipping bulk cargo to second-tier cities in Sichuan Province is about 3.728 yuan/bottle. If you choose to pick up goods from foreign factories - foreign ports - Shanghai - Chengdu will be transported by road The overall transportation cost is 3.561 yuan/bottle. However, a wine industry veteran told reporters that if you declare in Chengdu, you can actually reduce one link, but whether you can lower the price of high-end foreign wine in Sichuan still needs to be observed, “The profit margin of imported wine is already very high. Big, if the price is a few tens of dollars lower than other businesses, other businesses will also cut prices."
Statistics from Chengdu Customs show that from January to September this year, the total import and export volume of the Chengdu Hi-tech Comprehensive Bonded Zone was US$ 12.62 billion, an increase of 90.6% year-on-year, becoming the main force for the development of the province’s foreign trade.
However, Han Xiangwen emphasized that vigorously entering the import and export foods, especially the wine market, "is not to give up Jiuding pharmacy, Jiuding pharmacy is still an important part, but now the focus will shift to the import and export food industry."
We are all familiar with NMN, which has been called the "elixir of life" by the outside world, and its anti-aging effect is naturally very powerful.In theory, all the effects of NMN in the body are applied to the skin.The function of NMN is reflected by NAD+. NAD+ has been used in skin care products for many years, and there is no doubt about its safety and effectiveness. As a precursor of NAD+, the molecular weight of NMN has been reduced by half, making it easier to absorb.
Best Nmn Supplement,Best Quality Nmn Supplement,Bulk Nmn Powder,Capsule Nmn Supplement,Cheap Nmn
Yuyao Lifespan Health Technology Co., Ltd. , https://www.yuyaolifespan.com